Piperazine-substituted derivatives of favipiravir for Nipah virus inhibition: What do in silico studies unravel?

ABSTRACT: Favipiravir is found to show excellent in-vitro inhibition activity against Nipah virus. To explore the structure-property relationship of Favipiravir, in silico designing of a series of piperazine substituted Favipiravir derivatives are attempted and computational screening has been done to evaluate its bimolecular interactions with Nipah virus. The geometrical features of all the molecules have been addressed from Density Functional Theory calculations. Chemical reactivity descriptor analysis was carried out to understand various reactivity parameters. The drug-likeness properties were estimated by a detailed ADMET study. The binding ability and the mode of binding of these derivatives into the Nipah virus are obtained from molecular docking studies. Our calculations show greater binding

SUBMITTER: Lipin R 

PROVIDER: S-EPMC7799160 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature